European/Canadian multicenter, double‐blind, randomized, placebo‐controlled study of the effects of glatiramer acetate on magnetic resonance imaging–measured disease activity and burden in patients with relapsing multiple sclerosis

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Annals of Neurology

Topics

Medicine

Epidemiology

Pathology

Internal Medicine

Surgery

Show all topics

DOI

10.1002/ana.64